Trial Profile
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe Cystic Fibrosis Lung Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jul 2019
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 05 Feb 2018 Status changed from recruiting to completed.
- 29 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 29 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.